Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Return on Invested Capital: 2012-2020

Historic Return on Invested Capital for Avadel Pharmaceuticals (AVDL) over the last 8 years, with Dec 2020 value amounting to 0.01%.

  • Avadel Pharmaceuticals' Return on Invested Capital rose 87.00% to 0.02% in Q3 2020 from the same period last year, while for Sep 2020 it was 0.02%, marking a year-over-year increase of 87.00%. This contributed to the annual value of 0.01% for FY2020, which is 22.00% up from last year.
  • Avadel Pharmaceuticals' Return on Invested Capital amounted to 0.01% in FY2020, which was up 104.88% from -0.21% recorded in FY2019.
  • In the past 5 years, Avadel Pharmaceuticals' Return on Invested Capital ranged from a high of 1.02% in FY2017 and a low of -0.86% during FY2018.
  • Its 3-year average for Return on Invested Capital is -0.36%, with a median of -0.21% in 2019.
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Return on Invested Capital slumped by 189bps in 2018, and later spiked by 65bps in 2019.
  • Over the past 4 years, Avadel Pharmaceuticals' Return on Invested Capital (Yearly) stood at 1.02% in 2017, then crashed by 189bps to -0.86% in 2018, then spiked by 65bps to -0.21% in 2019, then increased by 22bps to 0.01% in 2020.